47634
Fmoc-Met-OH
≥98.0% (HPLC), for peptide synthesis
別名:
Fmoc-L-メチオニン
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
実験式（ヒル表記法）:
C20H21NO4S
CAS番号:
分子量:
371.45
NACRES:
NA.26
PubChem Substance ID:
UNSPSC Code:
12352209
EC Number:
276-258-5
MDL number:
Beilstein/REAXYS Number:
4300266
製品名
Fmoc-Met-OH, ≥98.0% (HPLC)
InChI key
BUBGAUHBELNDEW-SFHVURJKSA-N
InChI
1S/C20H21NO4S/c1-26-11-10-18(19(22)23)21-20(24)25-12-17-15-8-4-2-6-13(15)14-7-3-5-9-16(14)17/h2-9,17-18H,10-12H2,1H3,(H,21,24)(H,22,23)/t18-/m0/s1
SMILES string
CSCC[C@H](NC(=O)OCC1c2ccccc2-c3ccccc13)C(O)=O
assay
≥98.0% (HPLC)
optical activity
[α]20/D -29.5±1.5°, c = 1% in DMF
reaction suitability
reaction type: Fmoc solid-phase peptide synthesis
mp
121-123 °C (lit.)
application(s)
peptide synthesis
functional group
Fmoc
storage temp.
2-8°C
Quality Level
類似した製品をお探しですか？ 訪問 製品比較ガイド
関連するカテゴリー
保管分類
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
47634-VAR-F: + 47634-1G-F: + 47634-100G-F: + 47634-50G-F: + 47634-1KG-F: + 47634-PM: + 47634-25G-F: + 47634-5G-F: + 47634-BULK-F:
jan
Carolyn C Woodroofe et al.
Chembiochem : a European journal of chemical biology, 21(4), 508-516 (2019-08-01)
The reversible oxidation of methionine residues in proteins has emerged as a biologically important post-translational modification. However, detection and quantitation of methionine sulfoxide in proteins is difficult. Our aim is to develop a method for specifically derivatizing methionine sulfoxide residues.
Dennis Kubiczek et al.
Macromolecular bioscience, 20(4), e2000005-e2000005 (2020-02-28)
The pathogenic yeast Candida auris has received increasing attention due to its ability to cause fatal infections, its resistance toward important fungicides, and its ability to persist on surfaces including medical devices in hospitals. To brace health care systems for
Marcus Pickhardt et al.
Current Alzheimer research, 14(7), 742-752 (2017-02-06)
Anti-aggregation drugs play an important role in therapeutic approaches for Alzheimer's disease. We have previously developed a number of compounds that are able to inhibit the pathological aggregation of Tau protein. One common obstacle to application is the limited penetration
Stefan Eissler et al.
Journal of peptide science : an official publication of the European Peptide Society, 23(10), 757-762 (2017-06-22)
In solid-phase peptide synthesis, the nominal batch size is calculated using the starting resin substitution and the mass of the starting resin. The starting resin substitution constitutes the basis for the calculation of a whole set of important process parameters
Zdenek Kukacka et al.
ChemMedChem, 13(9), 909-915 (2018-02-24)
α-Galactosidase (αGal) is a lysosomal enzyme that hydrolyses the terminal α-galactosyl moiety from glycosphingolipids. Mutations in the encoding genes for αGal lead to defective or misfolded enzyme, which results in substrate accumulation and subsequent organ dysfunction. The metabolic disease caused
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）